Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/1998
10/07/1998EP0605701B1 Cytodiagnosis method using alstonine as a selective marker, and diagnostic kit containing said marker
10/06/1998US5817873 Polyiodinated compounds, their preparation and their use as contrast media for radiology
10/06/1998US5817861 Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media
10/06/1998US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/06/1998US5817292 MR imaging compositions and methods
10/06/1998US5817291 Method of ultrasonic imaging comprising administering biocompatible spheres or particles
10/06/1998US5817290 Method of and test kit for mutagenesis testing
10/06/1998US5817289 Non-cluster type bismuth compounds
10/06/1998US5817028 Method and device for the provocation of air passage narrowing and/or the induction of sputum
10/06/1998CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates
10/01/1998WO1998042826A1 Tissue specific promoters
10/01/1998WO1998042825A1 A transgenic model of colon cancer and anal cancer
10/01/1998WO1998042735A1 Novel monomer elements for marking peptidic nucleic acids
10/01/1998WO1998042384A1 Methods for delivering bioactive agents
10/01/1998WO1998042383A1 Charged lipids and uses for the same
10/01/1998WO1998020904A3 Microparticles filled with liquid acting according to a new principle and their use as diagnostic and therapeutic agents
10/01/1998DE19712530A1 Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren New monomer to mark peptide nucleic acids
10/01/1998CA2285413A1 Tissue specific promoters
10/01/1998CA2284735A1 A transgenic model of colon cancer and anal cancer
09/1998
09/30/1998EP0867729A1 Overhauser enhanced magnetic resonance imaging technique (OMRI or REDRI or ESREMPI)
09/30/1998EP0866723A2 Use of gaseous metallic complexes as ultrasound contrasting agents
09/30/1998EP0866655A2 Murine model for human carcinoma
09/30/1998EP0659056B1 Artifact-free imaging contrast agent
09/30/1998CN1194161A Preparing liquid for producing ultrasonic diagnostic contrast medium and the method of preparing contrast medium therewith
09/29/1998US5814599 Applying a patch to the skin which delivers therapeutic dosages
09/29/1998US5814317 Structural alterations of the EGF receptor gene in human gliomas
09/29/1998US5814301 Contrast agents for medical diagnosis of cardiovascular disorders
09/29/1998US5814300 Gene-targeted non-human mammals deficient in the SOD-1 gene
09/24/1998WO1998041540A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
09/24/1998WO1998041241A1 Mri contrast media recognizing minor environmental changes
09/24/1998WO1998041239A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
09/24/1998CA2284581A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
09/24/1998CA2284205A1 Mri contrast media recognizing microenvironmental changes
09/23/1998EP0865785A2 Antimicrobial caries-detecting composition
09/23/1998EP0734268A4 Xenogeneic tissue implant in ear pinna
09/23/1998CN1193952A Heterocyclic methyl free radicals as image enhancing agents
09/23/1998CN1193625A Polyazamacrocyclic compounds of complexation of metal ions
09/22/1998US5811581 Process for the purification of opacifying contrast agents
09/22/1998US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid
09/22/1998US5811405 Pharmaceuticals, diagnostic agents
09/22/1998US5811237 Sequence coding for protein expressed by campylobacter pylori
09/22/1998US5811077 Method of NMR imaging
09/22/1998US5811076 Macromolecular contrast media for MR imaging
09/22/1998US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix
09/22/1998US5809801 Cryogenic accumulator for spin-polarized xenon-129
09/22/1998CA2050679C Preparation of liposome and lipid complex compositions
09/17/1998WO1998040502A1 Peptide-enhanced transfections
09/17/1998WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
09/17/1998WO1998040106A1 Method of measuring physiological function
09/17/1998WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells
09/17/1998WO1998040049A2 Specific magnetosome, method for the production and use thereof
09/17/1998WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal
09/17/1998DE19716732A1 Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung Specific magnetosomes, processes for their preparation and their use
09/17/1998DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes
09/16/1998EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors
09/16/1998EP0863770A1 Contrast medium and its use
09/16/1998EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof
09/16/1998CN1193357A Oligonucleotide tags for sorting and identification
09/16/1998CN1192930A Contrast medium capable of eliminating in-stomach fluid level false shadow in CT scanning and use method thereof
09/15/1998US5808025 Polypeptide
09/15/1998US5808007 Treating cell proliferative or immunologic disorders
09/15/1998US5808005 Medical diagnosis; vaccines
09/15/1998US5807971 Core with polyoxaalkylene branches
09/15/1998US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
09/15/1998US5807879 Biotinidase-resistant biotinylated compound and methods of use thereof
09/15/1998US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
09/15/1998US5807536 Anatomical imaging with phycocyanins
09/11/1998WO1998039664A1 PROCESS FOR OBTAINING IMAGES AND SPECTRA OF THE EXTRACELLULAR pH BY MAGNETIC RESONANCE WITH EXTRINSINC INDICATORS CONTAINING ?1H OR 19¿F
09/11/1998WO1998039653A1 Methods for producing pure perlecan and other heparan sulfate proteoglycans
09/11/1998WO1998039288A1 Polydentate imines and their metal complexes
09/11/1998WO1998039277A1 Triarylmethyl free radicals as image enhancing agents
09/11/1998WO1998039036A1 X-ray contrast media
09/11/1998WO1998039035A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue
09/11/1998CA2282659A1 X-ray contrast media
09/09/1998EP0862432A1 Two-photon upconverting dyes and applications
09/09/1998EP0862420A1 Synthesis of drug nanoparticles by spray drying
09/09/1998CN1192733A Stable reagent for prepn. of radiopharmaceuticals
09/09/1998CN1192698A Prepn. and use of contrast agents
09/09/1998CN1192690A Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations
09/09/1998CN1192654A Novel embolizing compositions
09/08/1998US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
09/08/1998US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis
09/08/1998US5804389 Applying a cyanine dye labeling composition to a target site
09/08/1998US5804177 Method of using CD24 as a cell marker
09/08/1998US5804164 Water-soluble lipophilic contrast agents
09/08/1998US5804162 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
09/08/1998US5804161 A metal complex containing phosphine group used for diagnostic imaging
09/03/1998WO1998038513A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use
09/03/1998WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
09/03/1998CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
09/02/1998EP0861667A2 Particulate agents
09/02/1998EP0861259A1 Process for producing tungsten clusters
09/02/1998EP0861093A1 Non-invasive localization of a light-emitting conjugate in a mammal
09/02/1998EP0695138A4 Stabilization of voltage sensitive dyes
09/02/1998EP0533898B1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
09/02/1998CN1192160A Chelating polymers as contrast agents for medical imaging
09/02/1998CN1192159A Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients
09/02/1998CN1192128A Coatings for production of hyperpolarized noble gases
09/01/1998US5801229 Radiation sensitizers; antitumor agents
09/01/1998US5801228 Polymeric contrast agents for medical imaging